Share this page!

Suzanne Nielsen PhD MPS Profile picture
Twitter logo
16 Nov, 4 tweets, 4 min read
"Won't giving people #naloxone increase their drug use?" I get this question almost every time I deliver training to healthcare professionals. Superstar student @WaiChungTse1 led this systematic review to examine this common concern 1/ (FREE to download)
authors.elsevier.com/c/1e5JG_LkIBSl…
2/ So what did we do? We looked for studies where substance use and overdose was measured before and after naloxone provision. We found no evidence that take-home naloxone leads to increased substance use or overdose. 1 study found reduced ED attendances following naloxone supply
3/ So if you are providing naloxone, or thinking about it, this might be reassuring. If you train pharmacists, doctors, first responders etc and they have concern.. please feel free to share this work with them! @PSA_National @RACGP @ijdrugpolicy
authors.elsevier.com/c/1e5JG_LkIBSl…
4/ Finally, this was a great group of people to work with.. @WaiChungTse1 is a star to watch for, alongside Fil Djordevic & Paul Dietze (@BurnetInstitute ) Viandro Borja (@AlfredHealth), @LouisaPicco & @DrTinaLam_AU (@MonashAddiction), @AnnaM_Olsen, @SarahLarney .. a dream team!

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Suzanne Nielsen PhD MPS

Suzanne Nielsen PhD MPS Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrSuziNielsen

Suzanne Nielsen PhD MPS Profile picture
10 Nov
Last session for me today at @APSAD40 on prescription opioids, treatment, and prescription drug monitoring programs. First up - a mini-symposium with @PPrathivadi , @LouisaPicco and @Sarah_Haines_ .. lets see if I can pull out a few key findings 1/
2/ First up @PPrathivadi talking about GPs use of PDMP, benefits for informing prescribing but challenges with reluctance to use technology - also check out this super commentary with @Sarah_Haines_ in the @AusJPrimHealth on evaluation considerations
publish.csiro.au/py/PY20296
3/ Next is @LouisaPicco talking about implementation of prescription monitoring with #pharmacists. Alerts seem to really drive responses (over other clinical risk factors).. are automatic alerts replacing clinical judgement? Conclusion: PDMP should not replace clinical decisions
Read 8 tweets
Suzanne Nielsen PhD MPS Profile picture
10 Nov
Last afternoon of #APSAD40! It is a joy to chair this session on #overdose - lots of key learnings and great work in the prevention space. Here are a couple of highlights from the session 1/
2/ Louisa Durrant (NUM at Melaleuca, @qldhealthnews) spoke about lessons learned supplying take-home naloxone in the opioid treatment program in QLD. Despite many having experienced an overdose, few had access to naloxone before the pilot, and consumers valued being offered THN.
3/ Dr Eleanor Black presented on the ONE study, a pilot study looking at ED delivery of #naloxone - a key opportunity to offer naloxone to people at risk of overdose. Most (not all) staff through they should offer #naloxone, with common misconception of naloxone increased OD risk
Read 11 tweets
Suzanne Nielsen PhD MPS Profile picture
9 Nov
What's new in take-home #naloxone in Australia? 1/ Ange Matheson from @NSWHealth explains the NSW model which allows a whole range of workers and non-medical services across the NSW (e.g. those working NGOs without pharmacists or doctors on staff) to supply naloxone #APSAD40
2/ Tegan Nuckey from Queensland (QuIHN) talks about their #naloxone program, adapted from the WA model.. now funded until 2023 (but no recurrent funding). Hopefully a national program will be funded by then! No cost, script, no ID - addressing key barriers.
3/ Robin Greaves (Tasmania) presented on the Tasmanian gov program where poisons regulations were changed to allow supply by NPS workers as part of their pilot. With limited funding, the pilot focused on people who use heroin, now ongoing funding provides FREE naloxone from NSPs
Read 4 tweets
Suzanne Nielsen PhD MPS Profile picture
9 Nov
Big last day of #APSAD40 today for #opioid research. I'll be presenting in a symposium of #naloxone today, and then super excited to chair two sessions on #overdose and prescription #opioid treatment ... a couple of highlights include ... 1/
2/ New research on the implementation of prescription monitoring in Victoria with @LouisaPicco @PPrathivadi and @Sarah_Haines_ (all superstar PhD researchers in the @MonashAddiction crew)
3/ @DrTinaLam_AU (also from @MonashAddiction) presenting on prescription opioid overdose using emergency department data and @JMoullin from @CurtinUni talking about pharmacists and naloxone supply in Western Australia
Read 6 tweets
Suzanne Nielsen PhD MPS Profile picture
8 Aug
It's that time of year again, when I score grant apps for much of the weekend, and late into the weeknights too. Again, as I do each year, I implore you, grant writers, please do not use lots of acronyms in your grants, and don't make up your own acronyms. 1/ #AcademicTwitter
2/ This is particularly so for multidisciplinary grants. It is impossible that a panel member will be expert in every discipline, and you would be surprised how many acronyms mean different things in different disciplines.
3/ If you need to use acronyms to jam more words onto your page, forming the dreaded 'wall of text' ... think again. No one thanks you for this. It is really hard to find the key points you are making when every square cm of every page is jammed-packed with text.
Read 4 tweets
Suzanne Nielsen PhD MPS Profile picture
7 Apr 20
Advice from the DHHS about maintaining continuity for pharmacotherapy treatment is here. Key principals include writing prescriptions for longer (with regular phone check-ins with patients) and increased TA doses where clinically appropriate (1/3)
bit.ly/3e4EpSu
Guidance to support assessing appropriateness for additional takeaways are here. Where clinically appropriate, increasing takeaways means that people can stay safe at home and travel pharmacies. #Naloxone is recommended with takeaways bit.ly/2UQgmiy (2/3)
Documents to support dose delivery are here bit.ly/2RilpGe (3/3) Much credit to the dedicated staff at @VicGovDHHS @VAADAENEWS and the broader sector in developing these resources for those providing #methadone and #buprenorphine @psa_vic @HRV_Aust @RACGP @DrGrinzi
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @DrSuziNielsen has new unrolls!

Check out other threads from @DrSuziNielsen!

Read all threads by @DrSuziNielsen

:(